Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot

2 years ago

TORONTO, ON / ACCESSWIRE / January 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a…

Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)

2 years ago

Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery,…

ASCEND’s Telepresence Technology, Catalyst LIVE, Transforms Diagnostic Imaging

2 years ago

CHICAGO, IL / ACCESSWIRE / January 16, 2024 / ASCEND Cardiovascular's newest technology, Catalyst LIVE, currently implemented at two pioneering…

Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January

2 years ago

Uncle Bud’s, PBIO’s New Consumer Products Business Unit, Kicks Off 2024 with a $252,000 Shipment of Sunburn Soother to One of…

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

2 years ago

Reports initial reimbursements of CompuFlo® by commercial payors and MedicareROSELAND, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc.…

NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

2 years ago

Project reflects Scorpius’ versatility through its multi-functional biologics facility and expertise in microbial fermentationDURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE)…

Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference

2 years ago

BOSTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing…

Nanox Mourns Death of Its Founder, Ran Poliakine

2 years ago

PETACH TIKVA, Israel, Jan. 16, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative…

Biomerica Reports Second Quarter 2024 Financial Results

2 years ago

Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of…

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

2 years ago

– Patient dosing expected to begin mid-to-late Q1 2024 – CHARLESTOWN, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences…